Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Hirohito, Tada"'
Autor:
Satoshi Ikeda, Masahiro Tsuboi, Kazuko Sakai, Toshihiro Misumi, Hiroaki Akamatsu, Hiroyasu Shoda, Noriaki Sakakura, Atsushi Nakamura, Yasuhisa Ohde, Hidetoshi Hayashi, Kyoichi Okishio, Morihito Okada, Ichiro Yoshino, Jiro Okami, Kazuhisa Takahashi, Norihiko Ikeda, Masayuki Tanahashi, Yuichi Tambo, Haruhiro Saito, Shinichi Toyooka, Hidetoshi Inokawa, Toyofumi Chen‐Yoshikawa, Toshihide Yokoyama, Tatsuro Okamoto, Noriko Yanagitani, Masahide Oki, Makoto Takahama, Kenji Sawa, Hirohito Tada, Kazuhiko Nakagawa, Tetsuya Mitsudomi, Kazuto Nishio
Publikováno v:
Molecular Oncology, Vol 18, Iss 2, Pp 305-316 (2024)
The phase III IMPACT study (UMIN000044738) compared adjuvant gefitinib with cisplatin plus vinorelbine (cis/vin) in completely resected epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC). Although the primary endpo
Externí odkaz:
https://doaj.org/article/5ef9670861fa45fda1c2e13f031a8170
Autor:
Toshiaki Takahashi, Hirohito Tada, Kazuhisa Takahashi, Kenji Sugio, Hidetoshi Inokawa, Masahiro Tsuboi, Shunichi Sugawara, Hidetoshi Hayashi, Isamu Okamoto, Shinji Atagi, Noriaki Sakakura, Morihito Okada, Ichiro Yoshino, Kazuhiko Nakagawa, Hiroshige Yoshioka, Yasuo Iwamoto, Toshihiro Misumi, Tetsuya Mitsudomi, Masahiko Higashiyama
Publikováno v:
Journal of Clinical Oncology. 40:231-241
PURPOSE To investigate the efficacy of gefitinib as an adjuvant therapy for non–small-cell lung cancer patients with EGFR mutation. PATIENTS AND METHODS IMPACT (WJOG6410L; University Hospital Medical Information Network Clinical Trials Registry: UM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::527fa31d8a7a2fbc47079c772a8f1ef0
https://doi.org/10.1200/jco.21.01729
https://doi.org/10.1200/jco.21.01729
Autor:
Yoichi Nakanishi, Yasutaka Chiba, Masahiro Fukuoka, Makoto Oda, Kohei Yokoi, Hiroshi Semba, Hiroaki Nomori, Takashi Seto, Shunichi Negoro, Nobuyuki Katakami, Mitsunori Ohta, Mototsugu Shimokawa, Masafumi Yamaguchi, Toshiyuki Sawa, Masahiko Higashiyama, Kazuhiko Nakagawa, Motohiro Yamashita, Tetsuya Mitsudomi, Norihiko Iked, Hirohito Tada, Hideo Saka
Publikováno v:
International Journal of Clinical Oncology. 26:2216-2223
Adjuvant oral uracil-tegafur (UFT) has led to significantly longer postoperative survival among patients with non-small-cell lung cancer (NSCLC). Gemcitabine (GEM) monotherapy is also reportedly effective for NSCLC and has minor adverse events (AEs).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68675bc3e814502b66a255af6082803a
https://doi.org/10.1007/s10147-021-02012-9
https://doi.org/10.1007/s10147-021-02012-9
Autor:
Hirohito, Tada, Tetsuya, Mitsudomi, Toshihiro, Misumi, Kenji, Sugio, Masahiro, Tsuboi, Isamu, Okamoto, Yasuo, Iwamoto, Noriaki, Sakakura, Shunichi, Sugawara, Shinji, Atagi, Toshiaki, Takahashi, Hidetoshi, Hayashi, Morihito, Okada, Hidetoshi, Inokawa, Hiroshige, Yoshioka, Kazuhisa, Takahashi, Masahiko, Higashiyama, Ichiro, Yoshino, Kazuhiko, Nakagawa
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(3)
To investigate the efficacy of gefitinib as an adjuvant therapy for non-small-cell lung cancer patients withIMPACT (WJOG6410L; University Hospital Medical Information Network Clinical Trials Registry: UMIN000006252), a randomized, open-label, phase I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61ac5ae7eaf88ed738ce51aa15fc739d
https://pubmed.ncbi.nlm.nih.gov/34793259
https://pubmed.ncbi.nlm.nih.gov/34793259
Autor:
Morihito Okada, Kazuhiko Nakagawa, Hidetoshi Hayashi, Isamu Okamoto, Shinji Atagi, Toshiaki Takahashi, Hirohito Tada, Ichiro Yoshino, Hidetoshi Inokawa, Kenji Sugio, Shunichi Sugawara, Kazuhisa Takahashi, Takeharu Yamanaka, Noriaki Sakakura, Masahiro Tsuboi, Yasuo Iwamoto, Hiroshige Yoshioka, Tetsuya Mitsudomi, Masahiko Higashiyama
Publikováno v:
Journal of Clinical Oncology. 39:8501-8501
8501 Background: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor is a standard of care for EGFR mutation-positive, untreated metastatic non-small cell lung cancer (NSCLC). However, the efficacy and safety of adjuvant gefitinib for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::667a59b13c36cb0b785335e3373676a1
https://doi.org/10.1200/jco.2021.39.15_suppl.8501
https://doi.org/10.1200/jco.2021.39.15_suppl.8501
Autor:
Tonu Vanakesa, Oleg Gladkov, Katalin Udud, Patrick Therasse, Byoung Chul Cho, Jean-Louis Pujol, Moon Soo Kim, Libor Havel, Johan Vansteenkiste, Hans Hoffman, Nasser K. Altorki, Haruhiko Kondo, Paul D. Taylor, Jacek Jassem, Marcin Zieliński, Mei Lin Liao, Jamila Louahed, Tetsuya Mitsudomi, Tommaso De Pas, Konstantinos Zarogoulidis, Anders Bugge, Jubrail Dahabreh, Vincent Brichard, Muriel Debois, Haruhiku Nakayama, Jianxing He, Hirohito Tada, Masahiro Yoshimura, Emilio Esteban Gonzalez, C. Debruyne
Publikováno v:
The Lancet Oncology. 17:822-835
Summary Background Fewer than half of the patients with completely resected non-small-cell lung cancer (NSCLC) are cured. Since the introduction of adjuvant chemotherapy in 2004, no substantial progress has been made in adjuvant treatment. We aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cfba095f4c0d44aa7a2da0e05af827f
https://doi.org/10.1016/s1470-2045(16)00099-1
https://doi.org/10.1016/s1470-2045(16)00099-1
Autor:
Shinichi Toyooka, Hiroshi Date, Shinsuke Kajiwara, Keitaro Matsuo, Hiroshige Nakamura, Morihito Okada, Motohiro Yamashita, Hirohito Tada, Katsuyuki Hotta, Junichi Sakamoto, Motoi Aoe, Shinichiro Miyoshi, Masao Nakata, Norihito Okumura, Naoki Watanabe, Junichi Soh
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(5)
Introduction We conducted a randomized controlled study to compare the survival benefit of paclitaxel plus carboplatin and oral uracil-tegafur (UFT) as adjuvant chemotherapy in resected NSCLC. Methods In an open-label multicenter trial, patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b24f6745470a6bf3ac52e5ba333e5d
https://pubmed.ncbi.nlm.nih.gov/29703535
https://pubmed.ncbi.nlm.nih.gov/29703535
Autor:
Akihide Matsumura, Meinoshin Okumura, Hirohito Tada, Cheng-long Huang, Ken Kodama, Mitsunori Ohta, Hajime Maeda, Masahiko Higashiyama, Makoto Takahama, Koichi Yoshikawa
Publikováno v:
Haigan. 55:1055-1064
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51d2d061f981a67fb6fe4744d47e4dee
https://doi.org/10.2482/haigan.55.1055
https://doi.org/10.2482/haigan.55.1055
Autor:
Kohei Yokoi, Yoichi Nakanishi, Noriyoshi Sawabata, Ichiro Yoshino, Meinoshin Okumura, Masaki Mori, Etsuo Miyaoka, Hideo Kobayashi, Hisao Asamura, Kotaro Kameyama, Kenji Eguchi, Norihito Okumura, Hirohito Tada, Yoshitaka Fujii
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 148:2659-2664
ObjectiveAlthough positive pleural lavage cytology (PLC) has been demonstrated to be closely associated with a poor prognosis for patients with lung cancer, it has not been incorporated into the TNM staging system of the Union for International Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a342208f5ec7fa98af20453553a3d71c
https://doi.org/10.1016/j.jtcvs.2014.07.090
https://doi.org/10.1016/j.jtcvs.2014.07.090
Autor:
Yasushi Sakamaki, Tositeru Tokunaga, Kenji Kimura, Eiichi Morii, Hiroshi Katsura, Masayoshi Inoue, Hiroshi Matsui, Hirohito Tada, Yukiyasu Takeuchi, Yasushi Shintani, Naoko Ose, Hajime Maeda, Kenjiro Fukuhara, Meinoshin Okumura, Teruo Iwasaki
Publikováno v:
Interactive cardiovascular and thoracic surgery. 26(1)
Objectives A thymic neuroendocrine tumour (TNET) is rare, and few comprehensive reports of treatment results have been presented. To clarify the clinicopathological characteristics of TNET in affected patients, outcomes were retrospectively examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::871d4aa98e275cf822e09af959744e26
https://pubmed.ncbi.nlm.nih.gov/29049806
https://pubmed.ncbi.nlm.nih.gov/29049806